Genmont Biotech Incorporation

China Medical University

Genmont Biotech Inc.

Chih-Ho Lai

Wan-Hua Tsai

Yu-Hsin Lin

Yi-Hsing Chen

Wen-Ling Yeh

Ya-Hui Chen

Chia-Lin Wu

I-ling Hsu

Chia-Shuo Chang

Yao-Tsung Yeh

Cheng-Hsieh Huang

Cheng-Kuo Lai

The present invention provides acomposition and a use thereof for improving anxiety caused by antibiotics, wherein thecomposition comprisesGMNL-141,GM-020,GMNL-185, or a combination thereof. Thecomposition can effectively improve imbalance of an individual's intestinal flora caused by antibiotics to help stabilize and increase species richness and increase the synthesis of mood-stabilizing compounds, including flavonoids, flavonols, isoquinoline alkaloids, niacinamide, nicotinamide, and short-chain fatty acids in intestine, and thus effectively improve antibiotic-induced with anxiety disorders.

composition and use thereof for improving anxiety caused by antibiotics

A probiotic composition of improving memory and learning ability is disclosed. The probiotic composition comprisesGMNL-185 andGMNL-680, wherein theGMNL-185 was deposited in the China Center for Type Culture Collection in Wuhan, China on Nov. 3, 2017 under an accession number CCTCC NO. M 2017764, and theGMNL-680 was deposited in the China Center for Type Culture Collection in Wuhan, China on Nov. 3, 2017 under an accession number CCTCC NO. M 2017766, wherein a ratio of a number of bacteria of theGMNL-185 to a number of bacteria of theGMNL-680 is 1:1.

Method of improving memory and learning ability

The present invention provides a pharmaceutical composition and a food product for inhibiting gastritis induced by gastric, comprisingselected from a group composed ofGM-020 (also known as GMNL-74) with deposited number CCTCC M203098;GMNL-185 with deposited number CCTCC M2017764; andGMNL-662 with deposited number CCTCC M2016571; and any two of the above bacteria.

Lactobacillus composition for inhibiting gastritis induced by gastric helicobacter pylori and use thereof

A method for reducing the radio-resistance of prostate cancer cells in a subject in need thereof, comprising administering to the subject an effective amount of an active component, wherein the active component is a nanoparticle of a carrier encapsulated with cytolethal distending toxin subunit B (CdtB).

Method for reducing radio-resistance of prostate cancer cells and/or treating prostate cancer

Growing community of inventors

Taipei, Taiwan

Chih-Ho Lai